Compare Eaton Corporation plc (ETN) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Zimmer Biomet Holdings Inc — how do they compare? Eaton Corporation plc trades at $429.65 (market cap $164.88B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Eaton Corporation plc is far larger — about 9.7× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.08%). Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| ETN | ZBH | |
|---|---|---|
Market Cap | $164.88B | $16.95B |
Volume | 2,535,086 | 2,505,240 |
Sector | Industrials | Health |
52-Week High | $459.96 | $103.98 |
52-Week Low | $315.82 | $79.58 |
Typical Hold Time | 31 Days | 89 Days |
Enterprise Value | $185.51B | $24.02B |
Dividend Yield | 1.04% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton (ETN) trades at $424.51, down 1.58% over the past day, amid a bearish technical signal. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Strong profitability metrics include a 12.75% net income margin and 19.71% ROE. Recent news highlights strategic acquisitions in data center and utility markets, positioning the company for durable growth from AI and grid modernization trends.
Outlook remains positive with a consensus price target of $502.38, implying significant upside. Risks include execution of acquisitions and potential margin pressure from increased investing outlays. Analyst sentiment is strongly bullish with 70% buy ratings, though technical indicators suggest near-term caution.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
